Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02319837
Title Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Medivation, Inc.
Indications

prostate adenocarcinoma

Therapies

Leuprolide

Enzalutamide

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | CAN | AUT


No variant requirements are available.